Raw Material Compliance in Pharmaceuticals

I. Definition of Raw Materials – Regulatory Perspective

1. US FDA (21 CFR & FDA GMP Guidance)

Raw materials are any substances used in the manufacture of a drug substance or drug product, including active ingredients, excipients, processing aids, reagents, solvents, intermediates, and starting materials, that may affect the identity, strength, quality, or purity of the drug.

Key Regulatory References :

• 21 CFR 210 & 211
• ICH Q7 (adopted by FDA)

FDA Expectation :

• Raw materials must be tested or verified before use
• Suppliers must be qualified
• Materials must be traceable and controlled
• Any material that can impact product quality is considered a raw material, even if it is removed later (e.g., solvents, reagents)

2. EMA (EudraLex & ICH Guidelines)

Raw materials are all substances used in the manufacture of an active substance or medicinal product, including starting materials, intermediates, reagents, solvents, excipients, and materials used in processing, which can influence the quality, safety, or efficacy of the medicinal product.

Key Regulatory References :

• EudraLex Volume 4 (EU GMP)
• ICH Q7, Q11

EMA Expectation :

• Clear distinction between starting materials and intermediates
• Defined specifications where appropriate
• Full supply chain transparency
• Risk-based control of raw materials impacting CQAs

3. WHO (WHO GMP & Technical Report Series)

Raw materials are any substances, whether active or inactive, used in the manufacture of a pharmaceutical product, including active ingredients, excipients, starting materials, intermediates, solvents, reagents, and processing aids.

Key Regulatory References :

• WHO GMP for Pharmaceutical Products
• WHO TRS 986, 957, 1010

WHO Expectation :

• All raw materials must be approved, tested, and released before use
• Proper labeling, storage, and status identification
• Control of materials intended to be removed (e.g., solvents)
• Strong focus on developing countries and climatic conditions

Regulatory bodies such as USFDA, EMA, and WHO require that all raw materials meet strict quality standards and are controlled through validated processes, specifications, and supplier qualification programs.

II. Types of Raw Materials in Pharmaceuticals

In API manufacturing, the raw materials used include starting materials, intermediates, reagents, and solvents, all of which directly affect the quality of the API. The API itself then becomes a raw material for drug product manufacturing, highlighting the continuous and interconnected role of raw material control across the pharmaceutical supply chain.

In drug product manufacturing, the key raw materials used are API(s), excipients, packaging components, certain process aids (e.g., filters, gases) that can affect quality, safety and efficacy of the drug product.

Pharmaceutical raw materials can be broadly classified into the following major categories.

1. Drug Substance or Active Pharmaceutical Ingredients (APIs)

APIs are the active components responsible for the therapeutic effect of a drug. Once the manufacturing process is complete, the output of drug substance manufacturing, the API becomes a raw material for drug product (finished dosage form) manufacturing.

Examples: Paracetamol, Metformin, Rosuvastatin, Insulin analogs (biologics)

The API is supplied with a Certificate of Analysis (CoA) and released by Quality Assurance. It must meet approved specifications for identity, purity, potency, and impurities.

In drug product manufacturing, the API is treated as a critical raw material, combined with excipients to produce the final dosage form (tablets, capsules, injections, etc.).

Role of the API is to provide pharmacological activity, to determine dose strength, to define therapeutic indication, to influence stability and bioavailability.

APIs undergo extensive characterization (identity, purity, potency) and are regulated under ICH Q11 and Q7.

2. Excipients

Excipients play a critical and multifunctional role in drug product (finished dosage form) manufacturing. Although pharmacologically inactive, excipients are essential to ensure the quality, safety, efficacy, manufacturability, and patient acceptability of the drug product. Regulatory authorities (US FDA, EMA, WHO) treat excipients as critical raw materials due to their impact on Critical Quality Attributes (CQAs).

Excipients improve manufacturability, enhance stability & shelf life, control drug release (immediate/controlled) and improve patient acceptability.

1. Fillers / Diluents

   Provide bulk for tablets or capsules.
   Examples: Lactose, MCC, mannitol

2. Binders

   Help tablet granules adhere.
   Examples: PVP, HPMC

3. Disintegrants

   Aid tablet breakup.
   Examples: Croscarmellose sodium, Sodium starch glycolate

4. Lubricants & Glidants

   Ensure smooth compression, prevent sticking.
   Examples: Magnesium stearate, Talc

5. Coating Agents

   Improve appearance, stability, swallowability.
   Examples: HPMC, PEG, TiO₂

6. Preservatives

   Prevent microbial growth.
   Examples: Benzyl alcohol, Parabens

7. Buffers, Solvents, Surfactants

   Used in injectables, suspensions, and solutions.
   Examples: PBS, Polysorbate 80, Ethanol

3. Intermediates

• Intermediates are partially processed materials produced during the synthesis of the API or other raw materials and consumed in subsequent steps.
• They are formed from starting materials and further transformed into the final API.
• Critical intermediates may require in-process controls or specifications.
• Though not the final product, intermediates significantly influence impurity formation and yield.

Examples :

• A chemically modified compound produced after one or more reaction steps
• Key intermediates in antibiotic synthesis
• Precursors in peptide production

4. Reagents

Reagents are materials used to drive or facilitate chemical reactions but are not intended to become part of the final API structure.

• They enable reactions such as oxidation, reduction, coupling, or neutralization.
• Typically consumed or removed during processing.
• Their quality and purity must be controlled to avoid unwanted impurities.

Examples: Acids, bases, catalysts, or derivatizing agents.

5. Solvents

Solvents are used as reaction media, extraction agents, or purification aids.

• They help dissolve reactants, control reaction conditions, and enable crystallization or isolation.
• Residual solvent levels must comply with ICH Q3C guidelines.
• Solvent recovery, reuse, and traceability are important compliance aspects.

Examples: Methanol, acetone, ethyl acetate, acetonitrile, dichloromethane or water for injection.

6. Biological Raw Materials (Biologics Substrates)

Biological raw materials are materials derived from living sources (human, animal, plant, or microbial) used in the manufacture of drug substances or drug products.

Biological raw materials play a critical and high-risk role in pharmaceutical manufacturing, especially for biologics, vaccines, biotechnology products, and certain chemical drugs. Due to their biological origin and inherent variability, they require stricter control, traceability, and regulatory oversight than synthetic materials.

Examples: Cell banks (master and working cell banks), Microorganisms (bacteria, yeast), Enzymes, Growth media and supplements, Serum (e.g., fetal bovine serum), Blood- or plasma-derived materials, Biological buffers and proteins, Cell lines (CHO, HEK293), Viral vectors (AAV, Lentiviral), Plasmids

These are Subject to stringent GMP requirements (ICH Q5A, Q5D).

7. Packaging Raw Materials

Packaging raw materials include all materials used to contain, protect, transport, and identify a pharmaceutical product.

Packaging raw materials are essential to pharmaceutical quality systems. They protect the drug product, ensure safety, maintain stability, support efficacy, and enable regulatory compliance. In many cases, the shelf life of a drug product is defined as much by its packaging as by its formulation.

Primary and secondary packaging components.

Examples: Blister foils, Vials (glass Type I), Ampoules, Rubber stoppers, HDPE bottles

Packaging materials must be tested for extractables and leachables.

8. Process Aids & Auxiliary Materials

Process aids and auxiliary materials play a supportive yet critical role in pharmaceutical manufacturing. Although they are not intended to remain in the final drug product, regulatory authorities (US FDA, EMA, WHO) consider them quality-impacting materials because they can directly or indirectly affect the quality, safety, and efficacy of the drug product. As such, they must be identified, qualified, and controlled within the pharmaceutical quality system.

Examples: Chromatography resins, Filters and filter aids, Gases (nitrogen, compressed air, CO₂), Processing chemicals (antifoaming agents, release agents), Cleaning agents and disinfectants, Water systems (Purified Water, Water for Injection), Lubricants used in equipment (food/pharma grade).

Conclusion

Raw material compliance is a critical foundation of pharmaceutical quality, safety, and regulatory integrity. Each material whether an API, excipient, solvent, intermediate, biological substrate, packaging component, or process aid plays a specific and essential role in ensuring that the final drug product performs as intended. Regulatory authorities worldwide expect manufacturers to maintain stringent control over all raw materials through comprehensive specifications, supplier qualification, documentation review, and ongoing risk assessments.

Celegence provides comprehensive DMF authoring and filing services tailored to meet global regulatory requirements. Contact us at info@celegence.com.